Turk Ilac ve Serumnayi (IST:TRILC) Beneish M-Score: -0.66 (As of Jul. 03, 2026)


IST:TRILC Turk Ilac ve Serum Sanayi IST:TRILC
61 GF Score
Price ₺1.18
GF Value ₺3.60
Valuation Possible Value Trap
! 11 Warning Signs
View Full Analysis

What is Turk Ilac ve Serumnayi Beneish M-Score?

Turk Ilac ve Serumnayi IST:TRILC -2.48% 61 Beneish M-Score is -0.66 as of Jul. 03, 2026. GuruFocus rates IST:TRILC with a GF Score™ of 61/100 and a GF Value™ of ₺3.60 (Possible Value Trap). The stock has 11 warning signs investors should review. Among 909 Drug Manufacturers companies, Turk Ilac ve Serumnayi ranks worse than 93.62% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -0.66 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Turk Ilac ve Serumnayi's Beneish M-Score or its related term are showing as below:

IST:TRILC' s Beneish M-Score Range Over the Past 10 Years
Min: -3.92   Med: -0.66   Max: 25.97
Current: -0.66

During the past 5 years, the highest Beneish M-Score of Turk Ilac ve Serumnayi was 25.97. The lowest was -3.92. And the median was -0.66.


Turk Ilac ve Serumnayi Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Turk Ilac ve Serumnayi's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Turk Ilac ve Serumnayi Beneish M-Score Chart

Turk Ilac ve Serumnayi Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Beneish M-Score
0.00 0.00 21.46 -2.28 -1.43

Turk Ilac ve Serumnayi Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.50 -1.43 -2.76 -3.87 -0.66

IST:TRILC vs ZTS, UTHR, VTRS: Beneish M-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Turk Ilac ve Serumnayi's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Turk Ilac ve Serumnayi Beneish M-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Turk Ilac ve Serumnayi's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Turk Ilac ve Serumnayi's Beneish M-Score falls into.


IST:TRILC
61GF Score
Turk Ilac ve Serum Sanayi IST:TRILC
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Turk Ilac ve Serumnayi Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Turk Ilac ve Serumnayi for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.8605+0.528 * 1.2138+0.404 * 0.7736+0.892 * 0.9607+0.115 * 19.3548
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.2002+4.679 * -0.200952-0.327 * 1.281
=-0.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep25) TTM:Last Year (Sep24) TTM:
Total Receivables was ₺2,501 Mil.
Revenue was 1172.352 + 731.954 + 642.612 + 307.912 = ₺2,855 Mil.
Gross Profit was 394.473 + 220.119 + 164.573 + 8.461 = ₺788 Mil.
Total Current Assets was ₺3,676 Mil.
Total Assets was ₺6,124 Mil.
Property, Plant and Equipment(Net PPE) was ₺2,134 Mil.
Depreciation, Depletion and Amortization(DDA) was ₺4 Mil.
Selling, General, & Admin. Expense(SGA) was ₺281 Mil.
Total Current Liabilities was ₺3,174 Mil.
Long-Term Debt & Capital Lease Obligation was ₺762 Mil.
Net Income was 119.007 + -251.882 + -300.896 + -19.543 = ₺-453 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ₺0 Mil.
Cash Flow from Operations was 44.503 + 115.473 + 169.931 + 447.448 = ₺777 Mil.
Total Receivables was ₺1,400 Mil.
Revenue was 630.175 + 1006.484 + 480.482 + 854.605 = ₺2,972 Mil.
Gross Profit was 365.098 + 156.382 + 228.019 + 245.649 = ₺995 Mil.
Total Current Assets was ₺2,017 Mil.
Total Assets was ₺3,535 Mil.
Property, Plant and Equipment(Net PPE) was ₺1,283 Mil.
Depreciation, Depletion and Amortization(DDA) was ₺50 Mil.
Selling, General, & Admin. Expense(SGA) was ₺243 Mil.
Total Current Liabilities was ₺804 Mil.
Long-Term Debt & Capital Lease Obligation was ₺969 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(2501.497 / 2854.83) / (1399.567 / 2971.746)
=0.876233 / 0.470958
=1.8605

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(995.148 / 2971.746) / (787.626 / 2854.83)
=0.33487 / 0.275892
=1.2138

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (3676.42 + 2133.682) / 6124.193) / (1 - (2017.376 + 1282.799) / 3534.514)
=0.051287 / 0.0663
=0.7736

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=2854.83 / 2971.746
=0.9607

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(49.564 / (49.564 + 1282.799)) / (4.108 / (4.108 + 2133.682))
=0.0372 / 0.001922
=19.3548

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(280.578 / 2854.83) / (243.355 / 2971.746)
=0.098282 / 0.08189
=1.2002

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((761.96 + 3173.869) / 6124.193) / ((969.129 + 804.135) / 3534.514)
=0.642669 / 0.5017
=1.281

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-453.314 - 0 - 777.355) / 6124.193
=-0.200952

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Turk Ilac ve Serumnayi has a M-score of -0.66 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -0.66 mean?
Turk Ilac ve Serumnayi (IST:TRILC) has a Beneish M-Score of -0.66 as of Jul. 03, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Turk Ilac ve Serumnayi and its competitors. According to the industry distribution chart, Turk Ilac ve Serumnayi ranks #851 out of 909 companies in the Drug Manufacturers industry, placing it in the top 93.6%.
Is Turk Ilac ve Serumnayi's Beneish M-Score too high?
Turk Ilac ve Serumnayi's current Beneish M-Score is -0.66. Based on the distribution chart, Turk Ilac ve Serumnayi ranks #851 out of 909 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Turk Ilac ve Serumnayi has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Turk Ilac ve Serumnayi's Beneish M-Score compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Turk Ilac ve Serumnayi ranks #851 out of 909 companies for Beneish M-Score. This places Turk Ilac ve Serumnayi in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Drug Manufacturers company?
A good Beneish M-Score depends on the Drug Manufacturers industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Turk Ilac ve Serumnayi and its competitors. Turk Ilac ve Serumnayi's current Beneish M-Score is -0.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Turk Ilac ve Serumnayi stock overvalued right now?
Based on GuruFocus' analysis, Turk Ilac ve Serumnayi (IST:TRILC) is currently considered Possible Value Trap. The stock's GF Value™ is ₺3.60, compared to a current price of ₺1.18 — trading 67.2% below its estimated fair value. The current Beneish M-Score is -0.66. Turk Ilac ve Serumnayi's overall GF Score™ is 61/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Turk Ilac ve Serumnayi (IST:TRILC), the current Beneish M-Score is -0.66 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Turk Ilac ve Serumnayi (IST:TRILC) Overvalued in 2026?

Based on GuruFocus' analysis, Turk Ilac ve Serumnayi stock appears to be undervalued. The current stock price of ₺1.18 is trading 67.2% below its estimated GF Value™ of ₺3.60. GuruFocus considers Turk Ilac ve Serumnayi to be Possible Value Trap.

Key valuation signals for IST:TRILC:

  • Beneish M-Score: -0.66
  • GF Value™: ₺3.60 vs. price of ₺1.18 (67.2% below fair value)
  • GF Score™: 61/100 with 11 warning signs

No single metric tells the full story. See the IST:TRILC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Turk Ilac ve Serumnayi Business Description

Address Bugduz Mahalle Enver Pasa Cadde, No: 8 Akyurt, Ankara, TUR, TR 06750
Turk Ilac ve Serum Sanayi is engaged in the production of human pharmaceuticals and vaccines.
61GF Score

Get the complete analysis for IST:TRILC

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺1.18
Price
₺3.60
GF Value